US 11352402
Interleukin-4 receptor-binding fusion proteins and uses thereof
granted A61KA61K38/00A61K38/1761
Quick answer
US patent 11352402 (Interleukin-4 receptor-binding fusion proteins and uses thereof) held by Medicenna Therapeutics Inc. expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medicenna Therapeutics Inc.
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/00, A61K38/1761, A61K38/193, A61K38/2026